IQGAP2 expression is reduced and plays a tumor suppressor role in most solid cancer types wherein reduced levels of IQGAP2 correlated with poor overall survival of patients (gastric cancer [43], prostate cancer [44], hepatocellular carcinoma [45], ovarian cancer [46]). This evidence concerns the gene IQGAP2 and Familial prostate cancer.